Current effective treatment methods for interleukin-23/T helper type 17 cells pathway in rheumatologic and autoimmune diseases
Bilgesu Koyun1, Eda Özalp1, Oğuzhan Acet2, Oytun Erbaş3
1Dokuz Eylül Üniversitesi Tıp Fakültesi Öğrencisi, İzmir Türkiye
2Trakya Üniversitesi Tıp Fakültesi Öğrencisi, Edirne, Türkiye
3Demiroğlu Bilim Üniversitesi Tıp Fakültesi Fizyoloji Anabilim Dalı, İstanbul Türkiye
Keywords: Interleukin 17, Interleukin 23, rheumatologic disease, T helper 17 cell
The interleukin 23/T helper 17 pathway is involved in the mechanism of many autoimmune and rheumatologic diseases. The inhibition of inflammation by blocking receptors and cytokines in this pathway has become the main target for the development of novel therapeutic agents. Studies on these therapeutic agents are promising. Studies on these therapeutic agents are promising.